Clinical global impression: CIBIC‐Plus (Improvement) at 24 weeks 7‐point Likert scale · vascular dementia and other vascular cognitive impairments
Donepezil 10 mg showed no clear difference in clinical global impression: CIBIC‐Plus (Improvement) at 24 weeks… compared with placebo (moderate certainty).
1 finding from 1 review
Functional outcomes · vascular dementia and other vascular cognitive impairments
1 finding from 1 review
Adverse events (all adverse events) at 24 weeks · vascular dementia and other vascular cognitive impairments
Donepezil 10 mg leads to higher adverse events (all adverse events) at 24 weeks compared with placebo (high certainty).
1 finding from 1 review
Intervention not reported
Cognitive function ‐ the Cognitive portion of the Alzheimer Disease Assessment Scale ADAS‐Cog1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐ Wechsler Memory Scales WMS‐general memory score1 · Multiple sclerosis
1 finding from 1 review
Intervention not reported
Cognitive function ‐ Selective Reminding Test total SRT1 · Multiple sclerosis
1 finding from 1 review
Intervention not reported
Clinical global impression of change ‐ patient's self‐reported impression of memory change · Multiple sclerosis
The intervention showed no clear difference in clinical global impression of change ‐ patient's self‐reported… (high certainty).
1 finding from 1 review
Intervention not reported
Clinical global impression of change ‐ patient's self‐reported impression of cognitive change · Multiple sclerosis
The intervention showed no clear difference in clinical global impression of change ‐ patient's self‐reported… (high certainty).
1 finding from 1 review
Intervention not reported
Clinical global impression of change ‐ clinician's impression of memory change · Multiple sclerosis
The intervention showed no clear difference in clinical global impression of change ‐ clinician's impression of… (moderate certainty).
1 finding from 1 review
Intervention not reported
Clinical global impression of change ‐ clinician's impression of cognitive change · Multiple sclerosis
The intervention leads to higher clinical global impression of change ‐ clinician's impression of… (high certainty).
1 finding from 1 review
Intervention not reported
Activities of daily living ‐ Patient reported impact of multiple sclerosis activities Patient reported impact of multiple sclerosis activities1 · Multiple sclerosis
1 finding from 1 review
Intervention not reported
Cognitive function ‐ the Cognitive portion of the Vascular Alzheimer Disease Assessment Scale change V‐ADAS‐Cog1 · CADASIL
1 finding from 1 review
Intervention not reported
Clinical global impression of change ‐ the Sum of Boxes of the Clinical Dementia Rating Scale CDR‐SB1 · CADASIL
1 finding from 1 review
Intervention not reported
Activities of daily living ‐ Disability Assessment for Dementia scale DAD1 · CADASIL
1 finding from 1 review
Intervention not reported
Cognitive function ‐ the Unified Huntington's Disease Rating Scale‐Symbol Digit Modalities Test change UHDRS‐SDMT1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Nausea · Patients with neurological conditions associated with rarer dementias
The intervention leads to higher nausea (high certainty).
1 finding from 1 review
Intervention not reported
Diarrhea · Patients with neurological conditions associated with rarer dementias
The intervention probably leads to higher diarrhea (moderate certainty).
1 finding from 1 review
Intervention not reported
Vomiting · Patients with neurological conditions associated with rarer dementias
The intervention probably leads to higher vomiting (moderate certainty).
1 finding from 1 review
Intervention not reported
Cognitive function ‐ the Unified Huntington's Disease Rating Scale‐Verbal Fluency Test change UHDRS‐FAS1 · Huntington's disease
1 finding from 1 review
Intervention not reported
Cognitive function ‐ Verbal fluency test Verbal fluency test1 · Huntington's disease
1 finding from 1 review